


Akamis Bio Email Formats
Biotechnology Research • 4-10 The Quadrant, Barton Lane, United Kingdom • 21-50 Employees
Akamis Bio Email Formats
Akamis Bio uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@psioxus.com), used 63.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@psioxus.com | 63.6% |
{first initial}.{last name} | j.doe@akamisbio.com | 36.4% |
Key Contacts at Akamis Bio
Howard E. Davis
Chief Executive Officer
Philip Angell-Manning
Director Of Chemistry, Manufacturing & Controls Cmc
Company overview
| Headquarters | 4-10 The Quadrant, Barton Lane, Abingdon, Oxfordshire OX14 3YS, GB |
| Phone number | +441235835328 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
About Akamis Bio
Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Akamis Bio has 13 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Akamis Bio's funding history, including investment rounds, total capital raised, and key backers.
Akamis Bio Tech Stack
Discover the technologies and tools that power Akamis Bio's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
Frequently asked questions
4.8
40,000 users



